<code id='02AC2508B8'></code><style id='02AC2508B8'></style>
    • <acronym id='02AC2508B8'></acronym>
      <center id='02AC2508B8'><center id='02AC2508B8'><tfoot id='02AC2508B8'></tfoot></center><abbr id='02AC2508B8'><dir id='02AC2508B8'><tfoot id='02AC2508B8'></tfoot><noframes id='02AC2508B8'>

    • <optgroup id='02AC2508B8'><strike id='02AC2508B8'><sup id='02AC2508B8'></sup></strike><code id='02AC2508B8'></code></optgroup>
        1. <b id='02AC2508B8'><label id='02AC2508B8'><select id='02AC2508B8'><dt id='02AC2508B8'><span id='02AC2508B8'></span></dt></select></label></b><u id='02AC2508B8'></u>
          <i id='02AC2508B8'><strike id='02AC2508B8'><tt id='02AC2508B8'><pre id='02AC2508B8'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:5647
          A pair of scissor cuts four paper figures from a line of them — biotech coverage from STAT
          Adobe

          Sonata Therapeutics, a startup created two years ago through the merger of two Flagship Pioneering companies, has laid off about a third of its staff.

          The biotech laid off 21 employees in recent weeks, according to employee posts on social media and a company spokesperson. Sonata had around 63 employees before the layoffs.

          advertisement

          Sonata is just the latest in a series of startups laying off employees in order to stretch out their cash runways. Privately held startups have had a difficult time raising money during the recent biotech downturn, which has shown signs of abating in the last few months. But at this point, startups are still finding that private investors and venture capitalists are being cautious with their money as they wait to see if the downturn is truly over.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          Group opposing PBM reform sets lobbying record
          Group opposing PBM reform sets lobbying record

          Aconservativegroupadvocatingagainstchanginghowpharmacymiddlemenoperatespentmorethan$1milliononlobbyi

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

          DarronCummings/APThebenefitsandrisksofEliLilly’streatmentforAlzheimer’sdiseasewereconfirmedindetaile